Multiple Myeloma News
To Understand Human Disorders, Researchers Look to Man’s Best Friend
Source: Pharmacy Times articles Explore the intriguing connections between bulldogs and human medical conditions, revealing insights into congenital disorders and their treatments. Read More
Research Shows Diabetes Rewires the Brain, Mimicking Early Alzheimer Disease
Source: Pharmacy Times articles New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory. Read More
Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide
Source: Myeloma : nature.com subject feeds Post Content Read More
Targeting MTHFD2 alters metabolic homeostasis and synergizes with bortezomib to inhibit multiple myeloma
Source: Myeloma : nature.com subject feeds Post Content Read More
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma
Source: Myeloma : nature.com subject feeds Post Content Read More
Microcredentialing Opens New Doors for Pharmacy Technicians
Source: Pharmacy Times articles These short-term educational experiences can include specialized courses or training programs. Read More
JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition
Source: Pharmacy Times articles NS-229 is a Janus kinase 1 (JAK1) inhibitor being investigated in eosinophilic granulomatosis with polyangiitis, a rare autoimmune condition that can cause severe allergic and asthmatic symptoms through inflammation of nerve cells. Read...
Recent Clinical Trial Highlights for NSCLC Treatment
Source: Pharmacy Times articles A panelist discusses how recent clinical trials for EGFR-positive non–small cell lung cancer (NSCLC) have expanded treatment options beyond single oral agents, with studies like FLAURA2, MARIPOSA, and PAPILLON demonstrating significant...
Integrating Clinical Trial Findings Into Everyday Pharmacy Practice
Source: Pharmacy Times articles A panelist discusses how combining therapies for EGFR-positive non–small cell lung cancer (NSCLC) increases both benefits (improved progression-free survival, response rates, and duration of response) and adverse effects, emphasizing...
RSV and Aging: Understanding Increased Vulnerability
Source: Pharmacy Times articles New research reveals how aging weakens immune responses to RSV in older adults, increasing severity and hospitalization risks. Read More